Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 152

1.

Mortality Prediction in Rural Kenya: A Cohort Study of Mechanical Ventilation in Critically Ill Patients.

Parker RK, Mwachiro EB, Mwachiro MM, Pletcher J, Parker AS, Many HR.

Crit Care Explor. 2019 Dec 10;1(12):e0067. doi: 10.1097/CCE.0000000000000067. eCollection 2019 Dec.

2.

Surgical Training Throughout Africa: A Review of Operative Case Volumes at Multiple Training Centers.

Parker RK, Topazian HM, Ndegwa W, Chesang P, Strain S, Thelander K, Parker AS, Riviello R.

World J Surg. 2020 Mar 10. doi: 10.1007/s00268-020-05463-9. [Epub ahead of print]

PMID:
32157402
3.

Amorphous solid dispersions containing residual crystallinity: Influence of seed properties and polymer adsorption on dissolution performance.

Moseson DE, Parker AS, Beaudoin SP, Taylor LS.

Eur J Pharm Sci. 2020 Apr 15;146:105276. doi: 10.1016/j.ejps.2020.105276. Epub 2020 Feb 21.

PMID:
32092362
4.

National Analysis of Patients With Ulcerated Melanoma in the United States.

Boczar D, Sisti A, Restrepo DJ, Huayllani MT, Manrique OJ, Lu X, Spaulding AC, Bagaria SP, Parker AS, Forte AJ.

Anticancer Res. 2020 Feb;40(2):1055-1058. doi: 10.21873/anticanres.14042.

PMID:
32014953
5.

Concordance of PD-1 and PD-L1 (B7-H1) in paired primary and metastatic clear cell renal cell carcinoma.

Eckel-Passow JE, Ho TH, Serie DJ, Cheville JC, Houston Thompson R, Costello BA, Dong H, Kwon ED, Leibovich BC, Parker AS.

Cancer Med. 2020 Feb;9(3):1152-1160. doi: 10.1002/cam4.2769. Epub 2019 Dec 12.

6.

Influence of Facility Characteristics on Access to Breast Reconstruction: A 12-Year National Cancer Database Analysis.

Boczar D, Restrepo DJ, Sisti A, Huayllani MT, Spaulding AC, Gabriel E, Bagaria S, McLaughlin S, Parker AS, Forte AJ.

Anticancer Res. 2019 Dec;39(12):6881-6885. doi: 10.21873/anticanres.13907.

PMID:
31810957
7.

Disparity on Unplanned Readmission in Melanoma Patients: A National Cancer Database Analysis.

Boczar D, Restrepo DJ, Sisti A, Huayllani MT, Spaulding AC, Gabriel E, Bagaria S, Parker AS, Leppin AL, Forte AJ.

Anticancer Res. 2019 Dec;39(12):6877-6880. doi: 10.21873/anticanres.13906.

PMID:
31810956
8.

What Factors Define Limb Salvage or Amputation Surgery in Osteosarcoma of the Upper Extremities?

Huayllani MT, Restrepo DJ, Boczar D, Sisti A, Spaulding AC, Parker AS, Manrique OJ, Lu X, Wilke BK, Forte AJ.

Anticancer Res. 2019 Dec;39(12):6807-6811. doi: 10.21873/anticanres.13896.

PMID:
31810946
9.

Survival Disparities in Male Patients With Breast Cancer.

Restrepo DJ, Boczar D, Huayllani MT, Sisti A, McLaughlin SA, Spaulding A, Parker AS, Carter RE, Leppin AL, Forte AJ.

Anticancer Res. 2019 Oct;39(10):5669-5674. doi: 10.21873/anticanres.13764.

PMID:
31570465
10.

Osteosarcoma of the Upper Extremities: A National Analysis of the US Population.

Huayllani MT, Restrepo DJ, Boczar D, Sisti A, Spaulding AC, Parker AS, Sarabia-Estrada R, Guerrero-Cazares H, Moran SL, Forte AJ.

Anticancer Res. 2019 Oct;39(10):5663-5668. doi: 10.21873/anticanres.13763.

PMID:
31570464
11.

Which Factors Affect Survival in Patients With Upper Limb Osteosarcoma?

Restrepo DJ, Huayllani MT, Boczar D, Sisti A, Spaulding AC, Carter RE, Moran SL, Parker AS, Perdikis G, Forte AJ.

Anticancer Res. 2019 Sep;39(9):5027-5031. doi: 10.21873/anticanres.13693.

PMID:
31519610
12.

Exploring the Impact of Machine-Learned Predictions on Feedback from an Artificial Limb.

Parker ASR, Edwards AL, Pilarski PM.

IEEE Int Conf Rehabil Robot. 2019 Jun;2019:1239-1246. doi: 10.1109/ICORR.2019.8779424.

PMID:
31374799
13.

Real-World Hypoglycemia Avoidance With a Predictive Low Glucose Alert Does Not Depend on Frequent Screen Views.

Puhr S, Derdzinski M, Parker AS, Welsh JB, Price DA.

J Diabetes Sci Technol. 2020 Jan;14(1):83-86. doi: 10.1177/1932296819840691. Epub 2019 Apr 3.

PMID:
30943780
14.

Real-World Hypoglycemia Avoidance with a Continuous Glucose Monitoring System's Predictive Low Glucose Alert.

Puhr S, Derdzinski M, Welsh JB, Parker AS, Walker T, Price DA.

Diabetes Technol Ther. 2019 Apr;21(4):155-158. doi: 10.1089/dia.2018.0359. Epub 2019 Mar 22.

15.

Real-Time Sharing and Following of Continuous Glucose Monitoring Data in Youth.

Welsh JB, Derdzinski M, Parker AS, Puhr S, Jimenez A, Walker T.

Diabetes Ther. 2019 Apr;10(2):751-755. doi: 10.1007/s13300-019-0571-0. Epub 2019 Jan 30.

16.

The influence of obesity-related factors in the etiology of renal cell carcinoma-A mendelian randomization study.

Johansson M, Carreras-Torres R, Scelo G, Purdue MP, Mariosa D, Muller DC, Timpson NJ, Haycock PC, Brown KM, Wang Z, Ye Y, Hofmann JN, Foll M, Gaborieau V, Machiela MJ, Colli LM, Li P, Garnier JG, Blanche H, Boland A, Burdette L, Prokhortchouk E, Skryabin KG, Yeager M, Radojevic-Skodric S, Ognjanovic S, Foretova L, Holcatova I, Janout V, Mates D, Mukeriya A, Rascu S, Zaridze D, Bencko V, Cybulski C, Fabianova E, Jinga V, Lissowska J, Lubinski J, Navratilova M, Rudnai P, Benhamou S, Cancel-Tassin G, Cussenot O, Weiderpass E, Ljungberg B, Tumkur Sitaram R, Häggström C, Bruinsma F, Jordan SJ, Severi G, Winship I, Hveem K, Vatten LJ, Fletcher T, Larsson SC, Wolk A, Banks RE, Selby PJ, Easton DF, Andreotti G, Beane Freeman LE, Koutros S, Männistö S, Weinstein S, Clark PE, Edwards TL, Lipworth L, Gapstur SM, Stevens VL, Carol H, Freedman ML, Pomerantz MM, Cho E, Wilson KM, Gaziano JM, Sesso HD, Freedman ND, Parker AS, Eckel-Passow JE, Huang WY, Kahnoski RJ, Lane BR, Noyes SL, Petillo D, Teh BT, Peters U, White E, Anderson GL, Johnson L, Luo J, Buring J, Lee IM, Chow WH, Moore LE, Eisen T, Henrion M, Larkin J, Barman P, Leibovich BC, Choueiri TK, Lathrop GM, Deleuze JF, Gunter M, McKay JD, Wu X, Houlston RS, Chanock SJ, Relton C, Richards JB, Martin RM, Davey Smith G, Brennan P.

PLoS Med. 2019 Jan 3;16(1):e1002724. doi: 10.1371/journal.pmed.1002724. eCollection 2019 Jan.

17.

Prevalence of Nephrolithiasis in Patients with Chronic Liver Disease: A Case-Control Study.

Porter IE 2nd, Palmer WC, Parker AS, Hodge DO, Diehl NN, Haley WE.

J Clin Exp Hepatol. 2018 Dec;8(4):375-379. doi: 10.1016/j.jceh.2018.01.004. Epub 2018 Feb 11.

18.

Biomechanical Comparison of 3 Syndesmosis Repair Techniques With Suture Button Implants.

Parker AS, Beason DP, Slowik JS, Sabatini JB, Waldrop NE 3rd.

Orthop J Sports Med. 2018 Oct 24;6(10):2325967118804204. doi: 10.1177/2325967118804204. eCollection 2018 Oct.

19.

Crystallization Inhibition Properties of Cellulose Esters and Ethers for a Group of Chemically Diverse Drugs: Experimental and Computational Insight.

Mosquera-Giraldo LI, Borca CH, Parker AS, Dong Y, Edgar KJ, Beaudoin SP, Slipchenko LV, Taylor LS.

Biomacromolecules. 2018 Dec 10;19(12):4593-4606. doi: 10.1021/acs.biomac.8b01280. Epub 2018 Nov 12.

PMID:
30376299
20.

The Determinants of Palliative Care Use in Patients With Colorectal Cancer: A National Study.

Colibaseanu DT, Osagiede O, Spaulding AC, Frank RD, Merchea A, Mathis KL, Parker AS, Ailawadhi S.

Am J Hosp Palliat Care. 2018 Oct;35(10):1295-1303. doi: 10.1177/1049909118765092. Epub 2018 Mar 26.

PMID:
29580075
21.

High Tensile Strength of Engineered β-Solenoid Fibrils via Sonication and Pulling.

Peng Z, Parker AS, Peralta MDR, Ravikumar KM, Cox DL, Toney MD.

Biophys J. 2017 Nov 7;113(9):1945-1955. doi: 10.1016/j.bpj.2017.09.003.

22.

Alcohol consumption, variability in alcohol dehydrogenase genes and risk of renal cell carcinoma.

Antwi SO, Eckel-Passow JE, Diehl ND, Serie DJ, Custer KM, Wu KJ, Cheville JC, Thiel DD, Leibovich BC, Parker AS.

Int J Cancer. 2018 Feb 15;142(4):747-756. doi: 10.1002/ijc.31103. Epub 2017 Oct 28. Erratum in: Int J Cancer. 2018 Sep 1;143(5):E6.

23.

Multicenter Validation of Enhancer of Zeste Homolog 2 Expression as an Independent Prognostic Marker in Localized Clear Cell Renal Cell Carcinoma.

Ho TH, Kapur P, Eckel-Passow JE, Christie A, Joseph RW, Serie DJ, Cheville JC, Thompson RH, Homayoun F, Panwar V, Brugarolas J, Parker AS.

J Clin Oncol. 2017 Nov 10;35(32):3706-3713. doi: 10.1200/JCO.2017.73.3238. Epub 2017 Oct 4.

24.

Comprehensive Genomic Profiling of a Rare Thyroid Follicular Dendritic Cell Sarcoma.

Davila JI, Starr JS, Attia S, Wang C, Knudson RA, Necela BM, Sarangi V, Sun Z, Ren Y, Casler JD, Menke DM, Oliver GR, Joseph RW, Copland JA, Parker AS, Kocher JA, Thompson EA, Smallridge RC, Asmann YW.

Rare Tumors. 2017 Sep 15;9(2):6834. doi: 10.4081/rt.2017.6834. eCollection 2017 Jul 3.

25.

Validation of Gene Expression Signatures to Identify Low-risk Clear-cell Renal Cell Carcinoma Patients at Higher Risk for Disease-related Death.

Parasramka M, Serie DJ, Asmann YW, Eckel-Passow JE, Castle EP, Stanton ML, Leibovich BC, Thompson RH, Thompson EA, Parker AS, Ho TH, Joseph RW.

Eur Urol Focus. 2016 Dec 15;2(6):608-615. doi: 10.1016/j.euf.2016.03.008. Epub 2016 Apr 2.

PMID:
28723492
26.

Coffee consumption and risk of renal cell carcinoma.

Antwi SO, Eckel-Passow JE, Diehl ND, Serie DJ, Custer KM, Arnold ML, Wu KJ, Cheville JC, Thiel DD, Leibovich BC, Parker AS.

Cancer Causes Control. 2017 Aug;28(8):857-866. doi: 10.1007/s10552-017-0913-z. Epub 2017 Jun 24.

27.

Computationally optimized deimmunization libraries yield highly mutated enzymes with low immunogenicity and enhanced activity.

Salvat RS, Verma D, Parker AS, Kirsch JR, Brooks SA, Bailey-Kellogg C, Griswold KE.

Proc Natl Acad Sci U S A. 2017 Jun 27;114(26):E5085-E5093. doi: 10.1073/pnas.1621233114. Epub 2017 Jun 12.

28.

Genome-wide association study identifies multiple risk loci for renal cell carcinoma.

Scelo G, Purdue MP, Brown KM, Johansson M, Wang Z, Eckel-Passow JE, Ye Y, Hofmann JN, Choi J, Foll M, Gaborieau V, Machiela MJ, Colli LM, Li P, Sampson JN, Abedi-Ardekani B, Besse C, Blanche H, Boland A, Burdette L, Chabrier A, Durand G, Le Calvez-Kelm F, Prokhortchouk E, Robinot N, Skryabin KG, Wozniak MB, Yeager M, Basta-Jovanovic G, Dzamic Z, Foretova L, Holcatova I, Janout V, Mates D, Mukeriya A, Rascu S, Zaridze D, Bencko V, Cybulski C, Fabianova E, Jinga V, Lissowska J, Lubinski J, Navratilova M, Rudnai P, Szeszenia-Dabrowska N, Benhamou S, Cancel-Tassin G, Cussenot O, Baglietto L, Boeing H, Khaw KT, Weiderpass E, Ljungberg B, Sitaram RT, Bruinsma F, Jordan SJ, Severi G, Winship I, Hveem K, Vatten LJ, Fletcher T, Koppova K, Larsson SC, Wolk A, Banks RE, Selby PJ, Easton DF, Pharoah P, Andreotti G, Freeman LEB, Koutros S, Albanes D, Männistö S, Weinstein S, Clark PE, Edwards TL, Lipworth L, Gapstur SM, Stevens VL, Carol H, Freedman ML, Pomerantz MM, Cho E, Kraft P, Preston MA, Wilson KM, Michael Gaziano J, Sesso HD, Black A, Freedman ND, Huang WY, Anema JG, Kahnoski RJ, Lane BR, Noyes SL, Petillo D, Teh BT, Peters U, White E, Anderson GL, Johnson L, Luo J, Buring J, Lee IM, Chow WH, Moore LE, Wood C, Eisen T, Henrion M, Larkin J, Barman P, Leibovich BC, Choueiri TK, Mark Lathrop G, Rothman N, Deleuze JF, McKay JD, Parker AS, Wu X, Houlston RS, Brennan P, Chanock SJ.

Nat Commun. 2017 Jun 9;8:15724. doi: 10.1038/ncomms15724.

29.

GATA2 expression and biochemical recurrence following salvage radiation therapy for relapsing prostate cancer.

Robinson JL, Tzou KS, Parker AS, Heckman MG, Wu KJ, Hilton TW, Pisansky TM, Schild SE, Peterson JL, Vallow LA, Buskirk SJ.

Br J Radiol. 2017 Jul;90(1075):20170174. doi: 10.1259/bjr.20170174. Epub 2017 Jun 16.

30.

BAP1 and PBRM1 in metastatic clear cell renal cell carcinoma: tumor heterogeneity and concordance with paired primary tumor.

Eckel-Passow JE, Serie DJ, Cheville JC, Ho TH, Kapur P, Brugarolas J, Thompson RH, Leibovich BC, Kwon ED, Joseph RW, Parker AS.

BMC Urol. 2017 Mar 21;17(1):19. doi: 10.1186/s12894-017-0209-3.

31.

Differential gene expression profiling of matched primary renal cell carcinoma and metastases reveals upregulation of extracellular matrix genes.

Ho TH, Serie DJ, Parasramka M, Cheville JC, Bot BM, Tan W, Wang L, Joseph RW, Hilton T, Leibovich BC, Parker AS, Eckel-Passow JE.

Ann Oncol. 2017 Mar 1;28(3):604-610. doi: 10.1093/annonc/mdw652.

32.

Clear Cell Type A and B Molecular Subtypes in Metastatic Clear Cell Renal Cell Carcinoma: Tumor Heterogeneity and Aggressiveness.

Serie DJ, Joseph RW, Cheville JC, Ho TH, Parasramka M, Hilton T, Thompson RH, Leibovich BC, Parker AS, Eckel-Passow JE.

Eur Urol. 2017 Jun;71(6):979-985. doi: 10.1016/j.eururo.2016.11.018. Epub 2016 Nov 26.

33.

Whole-exome sequencing of a family with local anesthetic resistance.

Clendenen N, Cannon AD, Porter S, Robards CB, Parker AS, Clendenen SR.

Minerva Anestesiol. 2016 Oct;82(10):1089-1097. Epub 2016 May 31.

34.

Combinatorial localized dissolution analysis: Application to acid-induced dissolution of dental enamel and the effect of surface treatments.

Parker AS, Al Botros R, Kinnear SL, Snowden ME, McKelvey K, Ashcroft AT, Carvell M, Joiner A, Peruffo M, Philpotts C, Unwin PR.

J Colloid Interface Sci. 2016 Aug 15;476:94-102. doi: 10.1016/j.jcis.2016.05.018. Epub 2016 May 13.

PMID:
27209395
35.

Contrast-induced nephropathy in outpatients with preexisting renal impairment: a comparison between intravenous iohexol and iodixanol.

Cernigliaro JG, Haley WE, Adolphson DP, Jepperson MA, Crook JE, Thomas CS, Parker AS.

Clin Imaging. 2016 Sep-Oct;40(5):902-6. doi: 10.1016/j.clinimag.2016.04.008. Epub 2016 Apr 26.

PMID:
27183138
36.

An Examination of the Association between FOXA1 Staining Level and Biochemical Recurrence following Salvage Radiation Therapy for Recurrent Prostate Cancer.

Heckman MG, Robinson JL, Tzou KS, Parker AS, Wu KJ, Hilton TW, Howat WJ, Miller JL, Kreinest PA, Pisansky TM, Schild SE, Peterson JL, Vallow LA, Carroll JS, Buskirk SJ.

PLoS One. 2016 Mar 17;11(3):e0151785. doi: 10.1371/journal.pone.0151785. eCollection 2016.

37.

Author Reply.

Thiel DD, Davidiuk AJ, Meschia C, Serie D, Custer K, Petrou SP, Parker AS.

Urology. 2016 Mar;89:61-2. doi: 10.1016/j.urology.2015.10.039. Epub 2016 Jan 18. No abstract available.

PMID:
26797576
38.

Radical Prostatectomy Trends in the United States: 1998 to 2011.

Tyson MD 2nd, Andrews PE, Ferrigni RF, Humphreys MR, Parker AS, Castle EP.

Mayo Clin Proc. 2016 Jan;91(1):10-6. doi: 10.1016/j.mayocp.2015.09.018.

PMID:
26763510
39.

Mayo Adhesive Probability Score Is Associated With Localized Renal Cell Carcinoma Progression-free Survival.

Thiel DD, Davidiuk AJ, Meschia C, Serie D, Custer K, Petrou SP, Parker AS.

Urology. 2016 Mar;89:54-60. doi: 10.1016/j.urology.2015.10.034. Epub 2015 Dec 23.

PMID:
26723183
40.

Loss of histone H3 lysine 36 trimethylation is associated with an increased risk of renal cell carcinoma-specific death.

Ho TH, Kapur P, Joseph RW, Serie DJ, Eckel-Passow JE, Tong P, Wang J, Castle EP, Stanton ML, Cheville JC, Jonasch E, Brugarolas J, Parker AS.

Mod Pathol. 2016 Jan;29(1):34-42. doi: 10.1038/modpathol.2015.123. Epub 2015 Oct 30.

41.

Clear Cell Renal Cell Carcinoma Subtypes Identified by BAP1 and PBRM1 Expression.

Joseph RW, Kapur P, Serie DJ, Parasramka M, Ho TH, Cheville JC, Frenkel E, Parker AS, Brugarolas J.

J Urol. 2016 Jan;195(1):180-7. doi: 10.1016/j.juro.2015.07.113. Epub 2015 Aug 20.

42.

A Multidisciplinary Biospecimen Bank of Renal Cell Carcinomas Compatible with Discovery Platforms at Mayo Clinic, Scottsdale, Arizona.

Ho TH, Nateras RN, Yan H, Park JG, Jensen S, Borges C, Lee JH, Champion MD, Tibes R, Bryce AH, Carballido EM, Todd MA, Joseph RW, Wong WW, Parker AS, Stanton ML, Castle EP.

PLoS One. 2015 Jul 16;10(7):e0132831. doi: 10.1371/journal.pone.0132831. eCollection 2015.

43.

Comparison of patient-reported quality of life outcome questionnaire response rates between patients treated surgically for renal cell carcinoma and prostate carcinoma.

Thiel DD, Davidiuk AJ, Broderick GA, Arnold M, Diehl N, Tavlarides A, Custer K, Parker AS.

BMC Urol. 2015 Jul 1;15:58. doi: 10.1186/s12894-015-0057-y.

44.

High-resolution profiling of histone h3 lysine 36 trimethylation in metastatic renal cell carcinoma.

Ho TH, Park IY, Zhao H, Tong P, Champion MD, Yan H, Monzon FA, Hoang A, Tamboli P, Parker AS, Joseph RW, Qiao W, Dykema K, Tannir NM, Castle EP, Nunez-Nateras R, Teh BT, Wang J, Walker CL, Hung MC, Jonasch E.

Oncogene. 2016 Mar 24;35(12):1565-74. doi: 10.1038/onc.2015.221. Epub 2015 Jun 15.

45.

Whole exome sequencing of a patient with metastatic hidradenocarcinoma and review of the literature.

Gupta E, Guthrie KJ, Krishna M, Asmann Y, Parker AS, Joseph RW.

Rare Tumors. 2015 Feb 25;7(1):5719. doi: 10.4081/rt.2015.5719. eCollection 2015 Feb 11.

46.

Zinc transporter genes and urological cancers: integrated analysis suggests a role for ZIP11 in bladder cancer.

Wu L, Chaffee KG, Parker AS, Sicotte H, Petersen GM.

Tumour Biol. 2015 Sep;36(10):7431-7. doi: 10.1007/s13277-015-3459-2. Epub 2015 Apr 23.

47.

Prospective evaluation of the association of adherent perinephric fat with perioperative outcomes of robotic-assisted partial nephrectomy.

Davidiuk AJ, Parker AS, Thomas CS, Heckman MG, Custer K, Thiel DD.

Urology. 2015 Apr;85(4):836-42. doi: 10.1016/j.urology.2014.12.017. Epub 2015 Feb 7.

PMID:
25669734
48.

Whole-exome sequencing as a diagnostic tool in a family with episodic ataxia type 1.

Tacik P, Guthrie KJ, Strongosky AJ, Broderick DF, Riegert-Johnson DL, Tang S, El-Khechen D, Parker AS, Ross OA, Wszolek ZK.

Mayo Clin Proc. 2015 Mar;90(3):366-71. doi: 10.1016/j.mayocp.2015.01.001. Epub 2015 Feb 3.

49.

Mapping the Pareto optimal design space for a functionally deimmunized biotherapeutic candidate.

Salvat RS, Parker AS, Choi Y, Bailey-Kellogg C, Griswold KE.

PLoS Comput Biol. 2015 Jan 8;11(1):e1003988. doi: 10.1371/journal.pcbi.1003988. eCollection 2015 Jan.

50.

Comment on: the incidence and risk factors of metastasis for cutaneous squamous cell carcinoma--implications on the T-classification system.

Jambusaria-Pahlajani A, Karia PS, Parker AS, Schmults CD.

J Surg Oncol. 2015 Mar 15;111(4):483-4. doi: 10.1002/jso.23841. Epub 2014 Dec 9. No abstract available.

PMID:
25492622

Supplemental Content

Loading ...
Support Center